MedPath

云南南诏药业有限公司

Ownership
-
Established
2003-05-09
Employees
-
Market Cap
-
Website
http://www.gzyibai.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

38

NMPA:38

Drug Approvals

Ossotide Injection

Product Name
骨肽注射液
Approval Number
国药准字H53022164
Approval Date
Sep 18, 2020
NMPA

Thymopolypeptides Injection

Product Name
胸腺肽注射液
Approval Number
国药准字H53021765
Approval Date
Sep 18, 2020
NMPA

Thymopolypeptides Injection

Product Name
胸腺肽注射液
Approval Number
国药准字H53021766
Approval Date
Sep 18, 2020
NMPA

Cobratide Injection

Product Name
科博肽注射液
Approval Number
国药准字H53022101
Approval Date
Sep 5, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H53022157
Approval Date
Sep 5, 2020
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H53022161
Approval Date
Sep 5, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H53022156
Approval Date
Sep 5, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H53020424
Approval Date
Sep 5, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H53020428
Approval Date
Sep 5, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H53022008
Approval Date
Sep 5, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.